Cambridge Investment Research Advisors
PBH icon

Cambridge Investment Research Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,555
Closed -$2.7M – 4145
2026
Q1 		$2.7M Sell
45,555
-433
-0.9% -$28.1K 0.01% 1370
2025
Q4 		$2.84M Buy
45,988
+12,201
+36% +$747K 0.01% 1255
2025
Q3 		$2.11M Buy
33,787
+2,700
+9% +$188K 0.01% 1468
2025
Q2 		$2.48M Buy
+31,087
New +$2.6M 0.01% 1266

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors's PBH Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 45,555 shares — an estimated $2.7M sold.

Cambridge Investment Research Advisors first reported a position in PBH in Q2 2025 and held it in 4 quarters. The position peaked at $2.84M in Q4 2025. 321 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Cambridge Investment Research Advisors reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 45,555 Prestige Consumer Healthcare shares in Q2 2026, an estimated $2.7M.
  • Cambridge Investment Research Advisors first reported a position in Prestige Consumer Healthcare in Q2 2025 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Prestige Consumer Healthcare position peaked at $2.84M in Q4 2025.
  • 321 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.